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Since the first report more than a decade ago that bone
marrow (BM) stem cells transplantation could promote heart
regeneration following myocardial infarction (MI),1 different
types of stem cells have been examined. Among those
investigated to date, mesenchymal stem cells (MSCs) have
attracted huge interest owing to some of their unique proper-
ties that include easy isolation, high expandability and low
immunogenicity. Nonetheless despite the promising results of
animal studies and clinical trials, MSC-based therapy for MI
still faces some fundamental hurdles.2 One of the major
challenges is the poor cell engraftment and low cell-survival
rate following transplantation caused by the hostile environ-
ment of the injured heart and change to the immunologic
milieu of transplanted MSCs. In addition, the mechanisms of
stem cell-mediated tissue repair are not fully understood. Low
cell retention and poor myocardial differentiation cannot
explain the remarkable recovery of heart function following
MSCs treatment. Therefore, the paracrine effects of MSCs are
currently thought to have a predominant role. Although many
cytokines released from MSCs contribute to heart function
recovery,3 some are useless and even harmful.4 Thus, there is
an urgent need to optimize MSCs before their transplantation
to improve cell survival and augment their paracrine effects.
Recently, Rap1, a telomeric repeat binding factor 2 interacting
protein 1, has been identified as an important modulator of the
nuclear factor kappa-B (NF-κB) pathway.5,6 This pathway has
been reported to regulate MSCs secretion profiling and
survival.7,8 On the basis of these findings, modulation of the
NF-κB pathway to mediate MSCs therapy is feasible and
important. Nonetheless total deletion of NF-κB is lethal to
cells.9 Identification of an important regulator that can mediate
activity of the NF-κB pathway and subsequently regulate
MSC therapeutic efficacy for MI is vital. The roles of Rap1 in
regulation of MSCs and the underlying mechanisms have not
been classified, thus to understand how Rap1 regulates the
paracrine effects and cell survival of MSC-mediated heart
repair following infarction by regulation of the NF-κB pathway,
therefore, is important.10
In this study,10 wild-type BM-MSCs andRap1− /−-BM-MSCs
were derived from wild-type and Rap1− /− litter mate mice. It
appears that both wild type and Rap1 deficiency BM-MSCs
share the same MSCs properties including cell-surface
markers and multipotent-lineage differentiation potential.
Fluorescence-activated cell sorting confirmed that BM-MSCs
and Rap1− /−-BM-MSCs express Sca-1, CD90, CD105, but
not CD45 or CD34. Moreover, wild-type BM-MSCs and
Rap1− /−-BM-MSCs can differentiate into adipocytes, chon-
drocytes and osteocytes. The relationship of Rap1 and NF-κB
was examined. NF-κB activity of stromal cells was increased
by Rap1, as measured by pNF-κB-luciferase activity reporter
activity, and abolished by IkB dominant negative protein.
Knock down of Rap1 with shRap1 resulted in diminished
translocation of NF-κB-p65 from the cytoplasm to the
nuclei in response to TNF-α-stimulation. The cell survival of
Rap1− /−-BM-MSCs and wild-type BM-MSCs under normoxic
or hypoxic condition was investigated. There was no sig-
nificant difference in apoptosis of Rap1− /−-BM-MSCs and
wild-type BM-MSCs under normoxic conditions. Nonetheless
under hypoxic conditions, the apoptotic rate of Rap1− /−-BM-
MSCs was much lower than that of wild-type BM-MSCs.
This suggests that Rap1− /−-BM-MSCs are more tolerant
than wild-type BM-MSCs to hypoxia-induced apoptosis.
Meanwhile, Rap1− /−-BM-MSCs displayed a significantly
reduced ratio of phosphorylated NF-κB-p65 to NF-κB-p65
and ratio of Bax to Bcl-2 compared with wild-type BM-MSCs,
indicating that the absence of Rap1 enhances the resistance
of MSCs to the hypoxic challenge through regulation of NF-κB
activity. The resistance of Rap1− /−-BM-MSCs to apoptosis
was reduced when Rap1 was overexpressed in Rap1− /−-BM-
MSCs. Moreover, compared with wild-type BM-MSCs, pro-
inflammatory paracrine cytokines including TNF-α, IL-6 and
MCP-1 were greatly reduced in Rap1− /−-BM-MSCs in a
hypoxic environment. The cardioprotective effects of hypoxic-
conditioned medium (CdM) of Rap1− /−-BM-MSCs and wild-
type BM-MSCs were also tested. The apoptosis of neonatal
cardiomyocytes induced by hypoxia was significantly reduced
when co-cultured with Rap1− /−-BM-MSCs hypoxic-CdM
compared with wild-type BM-MSCs hypoxic CdM. The
increased cardioprotective effects of Rap1− /−-BM-MSCs
hypoxic CdM were reduced when Rap1− /−-BM-MSCs were
reconstituted with Rap1 re-expression. To further examine
the therapeutic effects of Rap1− /−-BM-MSCs in MI,
Rap1− /−-BM-MSCs and wild-type BM-MSCs were injected
into a mouse model of MI. Results revealed that 4 weeks
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following transplantation, the cell-survival rate in ischemic
heart tissue was much higher for Rap1− /−-BM-MSCs than
wild-type BM-MSCs but there was no significant difference in
differentiation into cardiomyocytes. Compared with wild-type
BM-MSCs, transplantation of Rap1− /−-BM-MSCs also
significantly improved heart function, prevented heart remo-
deling and reduced cardiomyocyte apoptosis. In addition,
transplantation of Rap1− /−-BM-MSCs greatly reduced the
inflammatory response in the ischemic heart compared with
BM-MSCs.
This study has several important findings (Figure 1). First,
the absence of Rap1 of MSCs strongly regulates secretion
profiling and especially reduces the release of pro-
inflammatory cytokines and enhances resistance to the
stressful challenge. Second, these paracrine effects are
attributed to the regulation of the NF-κB signal pathway by
Rap1. Third, transplantation of Rap1− /−-BM-MSCs greatly
improves heart function recovery following MI is associated
with reduced inflammation and enhanced cell survival. There-
fore, selective inhibition of Rap1 in BM-MSCs presents a novel
strategy to enhance future MSC-based therapy by regulating
paracrine profiling.
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Figure 1 Transplantation of Rap1− /−-BM-MSCs greatly improved heart function recovery post MI through reduction of inflammation and enhancement of cell survival that is
regulated by NF-κB signal pathway
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